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Abstract
Purpose
The purpose of this study is to 1) investigate the usefulness of five (5) objective early warning
signs; 2) evaluate the relationships between objective signs with symptoms of COVID-19, and 3)
assess the accuracy of ambient infrared forehead temperature with tympanic temperature.

Methods
Cross sectional data were collected at Wayne State University during the 2020-2021 semester.
Blood oxygen levels and blood pressure were measured via automated pulse oximeters and blood
pressure cuff, respectively. Body temperature was measured with an infrared thermometer via
contact with the temple (temporal temp) and non-contact with the forehead (infrared temp). The
smell test was conducted with two non-toxic scented markers. Participants were asked to identify
each smell from a provided list.

Results
Twenty-nine participants (nineteen in the Fall 2020 semester and ten in the Winter 2021
semester) consented to participate in vital sign testing. None of our participants confirmed a
positive COVID-19 test. Therefore, only relationships between vital sign measurements were
reported for these analyses (i.e. no COVID-19 positive versus COVID-19 negative analyses
could be performed, as per the original study design). No significant intra-variable correlations
were revealed upon statistical analysis. Infrared and temporal temperatures were not correlated
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with p=-0.252 and r=0.2196. A slight correlation between the fall and winter cohort was found
for heart rate only with p=0.51. Three participants had an oxygen saturation (O2) reading ≤ 90%,
without any associated symptoms. There were (non-significant) trends for those three
participants with low O2 saturation levels to have higher heart rate (94±25bpm vs. 79±14bpm;
p=0.11) and lower systolic blood pressure (111±21 vs. 120±12mmHg; p=0.27) compared with
those participants with O2 readings >90% (low O2 vs. normal O2 saturations, respectively).

Conclusion
Non-contact infrared thermometers are inaccurate at or above 99.5ºF; thus, they are an
ineffective way to screen for fever associated with COVID-19. Blood pressure is another
ineffective method for screening due to the lack of research on how COVID-19 affects blood
pressure without preexisting conditions. Heart rate could be another screening method; however,
it is unknown how SARS-CoV-2 affects the heart due to lack of research. Participants with low
oxygen saturation levels tended to have lower systolic blood pressures and higher heart rates,
indicating physiological disruptions unrelated to a positive COVID-19 test and requires further
investigation. Finally, smell may be a reliable method to screen for COVID-19 due to the high
prevalence of anosmia and early presentation when infected.
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Introduction
The coronavirus disease 2019 pandemic has plagued the world and is characterized by mass
shutdown, social isolation, conspiracy theories, and unprecedented vaccine development. First
reported in Wuhan provenance in mainland China, SARS-CoV-2, the novel coronavirus, has
been responsible for over 100 million positive cases and over 2.2 million deaths worldwide
(WHO Coronavirus Disease dashboard, n.d). SARS-CoV-2 affects the respiratory system
causing coronavirus disease 2019 (COVID-19), characterized by mild to severe symptoms (Hu et
al., 2020). The easy transmissibility via expired respiratory droplets containing SARS-CoV-2 has
led to a rapid global spread leading the World Health Organization to declare it a pandemic
(Ghebreyesus Adhanom, 2020). Two distinct categories of infection have emerged, symptomatic
cases and asymptomatic cases. Despite this, subtle physiological changes have suggested a
spectrum of COVID-19 pathophysiology ranging from seemingly asymptomatic to severe.

SARS-CoV-2 has four spike proteins on its outer envelope that allow it to bind to and infiltrate
host cells (Indwiani Ysragil, 2020). Attracted to angiotensin-converting enzyme two receptor
(ACE2), SARS-CoV-2 is prone to infect cells of the lower respiratory system (Rabi et al., 2020).
A myriad of symptoms is caused by COVID-19 ranging from abnormal vital signs (Tobin et al.,
2020; Wang 2020) to a loss of olfaction (Whitcroft & Hummel, 2020) and gustation (Luers et al.,
2020). Due to the objective presentation of symptoms, screening patrons for entry to public
spaces have become popular. Low blood oxygen saturation levels have been a commonly
reported clinical sign leading to happy hypoxia without any dyspnea (Tobin et al., 2020).
Further, SARS-CoV-2 can directly affect the heart by binding to the ACE2 receptors on the
myocardium leading to myocarditis (Topol, 2020) and arrhythmias (Goha et al., 2020). The virus
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also affects blood pressure by dysregulating the renin-angiotensin-aldosterone system (Topol,
2020). Each of these signs has an easy, non-invasive way to measure and report.

Screening via self-report of symptoms, travel disclosure, and non-contact forehead temperature
checks has become widespread. However, self-report measures and ambient forehead
thermometers have been shown to be inaccurate (Althubaiti, 2016; Niven, 2015). As such, the
aims of this study are to 1) investigate the usefulness of five (5) objective early warning signs; 2)
evaluate the relationships between objective signs with symptoms of COVID-19, and 3) assess
the accuracy of ambient infrared forehead temperature with tympanic temperature.

As the United States surpasses 571,000 deaths, the coronavirus pandemic remains an emergent
health crisis. As such, we hypothesize that elevations in heart rate and blood pressure, with or
without reductions in oxygen saturation and smell, may help identify “asymptomatic” SARSCoV-2 cases. Implementing simple, non-invasive screening methods can allow for the prediction
and early detection of COVID-19.

Increased screening methods are becoming more important as people who recover are left with
severe, lasting symptoms. Persistent symptoms for three weeks after recovery is known as postacute COVID-19 (Greenhalgh et al., 2020), often referred to as “long-COVID.” Any symptoms
present past that window are referred to as chronic-COVID (Chan et al., 2020). Long- and
chronic-COVID affect those who had severe symptoms, as well as those with mild symptoms. A
US study concluded that symptoms cease in a 14-to-21-day window for only 65% of people
infected with COVID-19 (Tenforde et al., 2020). The most-reported post-acute symptoms are

S.O.S. FOR COVID-19

Hughes 6

cough, low-grade fever, and fatigue on the mild end of the spectrum (Nalbandian et al., 2021).
Toward the more severe end, patients have presented with neurocognitive difficulties,
gastrointestinal problems, and metabolic disruption (Dasgupta et al., 2020).

Methods
The present study is of cross-sectional design. Prospective data were to be collected once a week
for in-person Life Fitness Activities (LFA) classes at Wayne State University in Detroit, MI, on a
voluntary basis during the fall 2020 semester. However, due to the increasing status of the
pandemic, data was only collected twice. Cross-sectional data were collected at Wayne State
University Campus Health Center COVID-19 testing sites on a voluntary basis during the winter
2021 semester. All participants signed written informed consent before testing began for this IRB
approved project (IRB-20-08-2665).

Blood oxygen saturation (O2) levels and blood pressure were measured via automated pulse
oximeters (Clinical Guard, Atlanta, GA, USA) and a blood pressure cuff (Omron, Model
BP785N, Lake Forest, IL) respectively. Body temperature was measured using a dual infrared
thermometer via contact with the temple (temporal temp) and non-contact with the forehead
(infrared temp) (Mesanfit, Shenzhen, China). The smell test was conducted with two non-toxic
scented markers Crayola Silly Scents Sweet and Smelly Markers, Easton, PA, USA). Participants
were asked to identify each smell from a provided list. Participants were contacted via email
after testing to follow up for positive test results.
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The blood pressure cuff was placed on the participant, and the pulse oximeter was placed on the
index finger of the opposite hand. Temperature was taken first via non-contact with the forehead
then with contact to the temple. After blood pressure and O2 saturation were recorded,
participants were asked to pull their masks below their noses and identify the scent of two
markers. Extra precautions were taken to prevent the stead of COVID-19. Researchers wore nonlatex disposable gloves and a mask. After data was collected, all equipment was disinfected
using a chlorine-based surface disinfectant.

Results
Twenty-nine participants (nineteen in the Fall 2020 semester and ten in the Winter 2021
semester) consented to participate in vital sign testing. None of our participants confirmed a
positive COVID-19 test. Therefore, only relationships between vital sign measurements were
reported for these analyses (i.e., no COVID-19 positive versus COVID-19 negative analyses
could be performed, as per the original study design).

The present study aimed to determine the usefulness of five non-invasive vital signs (blood
pressure, oxygen saturation, pulse, heart rate, and smell), evaluate the relationship with
subjective symptoms and objective signs and finally assess the accuracy of infrared temperature
checks with temporal temperature checks. Statistical analysis was performed on all data.
Descriptive statistics of the data set (n=29) are provided in table 1. An outlier in oxygen
saturation (56%) was found to be more than three standard deviations from the mean and
subsequently was removed from the results.
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Infrared temp has a mean of 96.8±1.49º, n=29. Temporal temp averaged 98.47±1.57º, n=29.
Systolic blood pressure and diastolic blood pressure averaged 119.17±13.26mmHg, n=29 and
73.52±7.8mmHg, n=29, respectively. The heart rate mean is reported as 80.69±15.53bpm, n=29.
O2 saturation with the outlier has a median of 95.17±8.13%. n=29. One outlier was identified
(O2 of 56%) and when removed from the data set, the median became 96.57±3.11%.
Relationships between each variable were run for correlations. No significant intra-variable
relationships were found.

Table 1. Descriptive statistics of data set. One O2 saturation outlier was removed due to being more than two
standard deviations outside of the mean.

Variable

Valid N

Mean

Minimum Maximum

Std.Dev.

Infrared Temp.

29

96.8379

92.3

98.6

1.48647

Temporal Temp.

29

98.4724

95.6

103.5

1.57001

SBP

29 119.1724

88

DBP

29

73.5172

56

HR

29

80.6897

55

O2 Saturation

29

95.1724

56

99

8.12874

O2 Saturation_NO OUTLIER

28

96.5714

84

99

3.10828

157 13.26399
90

7.80394

121 15.52901

Diastolic blood pressure (DPB) and systolic blood pressure (SBP) were not significantly related
with a p=0.253, r=0.2192, n=29. Infrared temperature and temporal temperature are not
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significantly correlated with p=0.252, r=0.2196, n=29. Heart rate (HR) and O2 saturation were
not related with p=-0.543, r=-0.0119, n=28. HR and SBP are not related with p=0.956, r=0.0108, n=29. HR and DBP are not related with p=0.487, r=0.1343, n=29. This data is available
in table 2.
Table 2 Statistical analysis to show relationships. No relationships between variables were significant. Marked
correlations are significant at p < 0.05000.
Variable
Infrared Temp.

Temporal Temp.

SBP

DBP

HR

O2 Saturation_NO OUTLIER

Infrared Temp.

Temporal Temp.

SBP

DBP

HR

1

O2 Saturation_NO OUTLIER

0.2196

-0.1503

-0.1446

0.1918

0.103

N=29

N=29

N=29

N=29

N=29

N=28

p= ---

p=.252

p=.436

p=.454

p=.319

p=.602

0.2196

1

-0.0775

-0.2337

0.2661

0.2667

N=29

N=29

N=29

N=29

N=29

N=28

p=.252

p= ---

p=.690

p=.222

p=.163

p=.170

-0.1503

-0.0775

1

0.2192

-0.0108

-0.1845

N=29

N=29

N=29

N=29

N=29

N=28

p=.436

p=.690

p= ---

p=.253

p=.956

p=.347

-0.1446

-0.2337

0.2192

1

0.1343

-0.3391

N=29

N=29

N=29

N=29

N=29

N=28

p=.454

p=.222

p=.253

p= ---

p=.487

p=.078

0.1918

0.2661

-0.0108

0.1343

1

-0.1199

N=29

N=29

N=29

N=29

N=29

N=28

p=.319

p=.163

p=.956

p=.487

p= ---

p=.543

0.103

0.2667

-0.1845

-0.3391

-0.1199

1

N=28

N=28

N=28

N=28

N=28

N=28

p=.602

p=.170

p=.347

p=.078

p=.543

p= ---

S.O.S. FOR COVID-19

Hughes 10

Table 3 shows statistics between Fall 2020 cohort and Winter 2021 cohort. Heart rate was the only factor that has a
slight correlation. Group 1 is the Fall 2020 cohort. Group 2 is the winter 2021 cohort.
Variable

Mean 2

Mean 1

t-value

df

p

Valid

Valid

N2

N1

Std.Dev. 2

Std.Dev.

F-ratio

p

1

Variances

Variances

Infrared Temp.

96.61

96.9579

-0.59207

27

0.558728

10

19

1.45255

1.52909

1.10818

0.913496

Temporal

98.01

98.7158

-1.15764

27

0.25715

10

19

1.3868

1.64055

1.39942

0.620907

SBP

115

121.3684

-1.24073

27

0.225377

10

19

13.40812

13.0009

1.06363

0.865038

DBP

71.4

74.6316

-1.06237

27

0.29748

10

19

7.21418

8.05682

1.24725

0.75988

73

84.7368

-2.04101

27

0.051136

10

19

10.42433

16.45142

2.49064

0.163766

92.1

96.7895

-1.51003

27

0.14265

10

19

13.42841

2.14939

39.03177

0

96.1111

96.7895

-0.53213

26

0.599154

9

19

4.67559

2.14939

4.73196

0.005933

Temp.

HR

O2 Saturation

O2
Saturation_NO
OUTLIER

Data for the fall and winter semesters were compared to identify any relationships between
cohorts. No significant relationships were observed, as seen in table 3. There was a small
relationship between cohorts seen in heart rate with a p = 0.051.
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Table 4 shows high O2 saturation versus low O2 saturation. Valid data was found with an O2 saturation above
90%. No significant factors were found.

p
Mea

Mea

t-

d

n0

n1

value

f

Variable

Valid

Valid

Std.D

Std.D

F-ratio

N0

N1

ev. 0

ev. 1

Variances

p

Varian
ces

96.7
Infrared Temp.

2
97.3

0.579

0.56

846

1.559
26

7

001

2

0.264

3

0.1269
0.4

15.2085

92

53

163

98.5
Temporal Temp.

1.13
97.5

846

120.
SBP

898

7

717

1.13

2

0.267

111
115

1.610
26

7

279

2

0.152

0.3418
0.7

5.2958

89

12.40
26

275

3

02

20.66

3

0.1633
2.7737

75

398

7.552

8.736

44

72.8

79.6

DBP

1.47
077

667

26
7

827

2

0.118

3

0.5609
1.3382

58

89

14.03

24.87

29

109
79.1
HR

94

1.61

538

26
7

3

583

0.1210
3.1444

052

971

1.349

18.14

64

754

1.349

4.242

33

204
97.3

76.6

6.62

2

O2 Saturation

0
077

667

845

7

8.98

2

26

3

180.7995

0

O2
97.3
Saturation_NO

87
077

OUTLIER

0
571

6

26

2

0.0085
9.8818

64

64

32
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Table 4 shows the difference between data sets when separated by high and low oxygen
saturation. When separated, minor changes were seen between groups. The low O2 saturation
group showed systolic blood pressure and higher diastolic blood pressure.

Discussion
Infrared thermometers are not an effective tool for pre-screening
Infrared temperature measures of the forehead have become commonplace as a quick, noninvasive way to screen for potential COVID-19 symptoms. The increased use of these tools has
brought their inaccuracies to light. The “gold standard” of body temperature measurement is the
pulmonary artery catheter (Bridges & Thomas, 2009). During this procedure, a catheter is
inserted via a large vein, then it is directed into the pulmonary vein, where the temperature of the
blood is recorded; this is considered a true “core body temperature” reading (Wright &
Mackowiak, 2020). When measuring via pulmonary artery catheter, the “normal” value can be
expected to be about 98.6ºF (37ºC) (Bridges & Thomas, 2009). Other common ways to take
temperature include oral, tympanic, temporal, axilla, and rectal. Each method has its strengths
and shortcomings. While no study to date has determined the correlation between these methods,
the clinical review board of the non-profit organization, HealthWise, determined that rectal and
tympanic temperatures are 0.5°F (0.3°C) to 1°F (0.6°C) higher than an oral temperature (Blahd
et al., 2020). The review board also reports that axillary and temporal are 0.5°F (0.3°C) to 1°F
(0.6°C) below oral readings (Blahd et al., 2020).

A study in a neuroscience ICU concluded that measurements taken at the urinary bladder and
temperatures taken via the pulmonary artery varied by 0.8ºC in 15% of patients. The study then
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compared tympanic temperature measurements to bladder measures and found that 35% had a
difference of 0.8ºC or higher, with 10% of those with a variance having a discrepancy of 1.5° C
or greater (Dunleavy, 2010). These variances lead Wright and Mackowiak (2021) to argue that a
proper encompassing body temperature does not exist; instead, there are only the temperatures of
individual body parts.

A more recent study published in the American Journal of Infection Control assessed the
accuracy of non-contact infrared thermometers (NCIT) with temporal artery thermometers
(TAT). Khan et al. (2020) found NCIT's to be related to TAT temperatures below 99.5ºF
(37.5°C). When temperatures are at or above 99.5ºF (37.5°C), the mean differences widened
considerably (Khan et al., 2020). In contrast with Khan et al., the current study found no
correlation at any temperature, as seen in graph 1. The data collected during this study revealed
no relationship between infrared temperature reading and temporal temperature reading. Also
revealed upon statistical analysis is no correlation between fall and winter cohorts regarding
temporal temperature (p=0.2572) and infrared temperature (p=0.5587), see figure 2. This
concludes that both methods of temperature readings are not helpful for screening. Fall infrared
temperature was expected to have been higher due to warmer weather and outside classes. This
change was not observed. Increased inaccuracies due to ambient temperature (Shajkofci, 2021)
further rendered infrared thermometers inadequate.
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Figure 1 shows no relationship between temporal temperature and infrared temperature, p=0.252, n=29. Dashed
lines represent upper and lower confidence intervals, while the solid line represents correlation.
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Figure 2 shows differences between cohorts. X represents the mean of each group. Fall vs. winter infrared temp. has
a p of 0.5587 and temporal temp. has a p of 0.2572.

In the midst of a flu-like pandemic, accurate temperature checks have become a tool to protect
and promote public health. The gold standard method to measure temperature remains an
invasive procedure, not suitable for field testing. Another limiting factor affecting temperature
checks is a lack of agreement surrounding an actual temperature (Chan, Kosik, & Wang, 2021).
The US Center for Diseases Control and Prevention [CDC] (2017) lists the criterion of fever
being a temperature reading of 100.4ºF or greater. As such, the errors in temperature readings
above 99.5ºF render temperature measurements via non-contact infrared thermometers
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impractical for COVID-19 screening. The inaccuracies at temperatures at or above 99.5ºF for
NCIT's raise significant problems for the COVID-19 pandemic.

Systolic blood pressure does not appear to be significantly linked to diastolic blood
pressure
Blood pressure is a large part of cardiovascular health, which is an essential indicator of overall
health. As such, blood pressure is a common vital used to assess such health due to its ease of
use and low cost. The virus that causes COVID-19 targets the cardiovascular system via the
ACE2 receptor (Rabi et al., 2020). Individuals with previous high blood pressure are at an
increased risk for a severe reaction to COVID-19 (Shah et al., 2021). The stress placed on the
body by SARS-CoV-2 would be expected to increase blood pressure due to its effect on the
renin-angiotensin-aldosterone system. To date, no study has assessed the effect of COVID-19 on
blood pressure. The opposite has been studied in-depth, i.e., how hypertension affects COVID19 outcomes.

The linear relationship between systolic blood pressure (SBP) and diastolic blood pressure
(DBP) is well studied and well understood (Pastor-Barriuso et al., 2003). SBP and DBP have
been linked together in several studies, often demonstrating a systolic-versus-diastolic slope
upon regression (Gavish, Ben-Dov, & Bursztyn, 2008). Both blood pressure readings coupled
with pulse pressure have been shown to be highly related. These three factors are said to be so
closely related that having two of the three provides enough data to determine the third. The
present study found SBP and DBP are not significantly correlated with a p=0.253 and an
r=0.2192, see figure 3.

S.O.S. FOR COVID-19

Hughes 17

Interestingly, the present article does not show a significant correlation; however, when SBP and
DBP are plotted and tracked, the data shows SBP and DBP following each other in certain
instances (see figure 4). Gavish, Ben-Dov, and Bursztyn (2008) explained this trend, citing that
changes in DBP can be seen as more prominent changes in SBP. The present cohort did not show
a high correlation; however, it did show similarities to previous studies in that regard.

As previously mentioned, no study to date has examined if COVID-19 causes changes in blood
pressure. As such, there is no significant research to determine if blood pressure monitoring
would be a good method to screen for COVID-19. However, if blood pressure were commonly
measured, individuals would be more in tune with their health. If a person trends with high blood
pressure, they would be able to take more precautions to prevent COVID-19 infection and
potential strong adverse reactions.

SPB vs DBP

r = 0.2192
p = 0.253

100
95

DPB (mmHg)

90
85
80
75
70
65
60
55
50
80

90

100

110
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130

140

150

160

SBP (mmHg)

Figure 3 Systolic blood pressure and diastolic blood pressure typically share a linear relationship. Seen in the
current study is a lack of linear relationship with p=0.2192

170
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SBP vs DBP
160

140
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Linear (SBP)
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Figure 4 demonstrates some consistency of systolic blood pressure (SBP) to reflect changes in diastolic blood
pressure (DBP).

O2 Stats
Oxygen (O2) saturation has been a perplexing piece of the SARS-CoV-2 puzzle. Hypoxia
without any dyspnea has been seen in many patients and subsequently been given the term
“happy hypoxia.” Patients have been reporting to hospitals with blood oxygen levels as low as
50% (Tobin, Laghi, &amp; Jubran, 2020), which is contradictory to life and would potentially
lead to brain damage or cell death. It is hypothesized that when SARS-CoV-2 s attaches to ACE2
receptors, it affects the carotid body, where blood oxygen receptors are located (Tobin, Laghi, &
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Jubran, 2020). The human body is more sensitive to decreases in levels of blood carbon dioxide
levels, which is not seen in COVID-19 infection. Based on this fact, we may be able to determine
a better way to monitor COVID-19 patients. A study published in the Journal for Laboratory
Medicine found that in a small population, COVID-19 patients show lower levels of oxygen and
higher carbon dioxide levels in the blood (Elezagic et al., 2020). The Elezagic et al. study results
open the door for a new way to screen for COVID-19. More studies are needed to validate CO2
as an efficient screening method.

The FDA reports that pulse oximeters have inaccuracies that are not clinically significant at
normal O2 saturation levels (Center for Devices and Radiological Health, 2021). When O2
saturation levels fall, the inaccuracies become more remarkable and more significant (Tobin,
Laghi, & Jubran, 2020). Race has been revealed to play a factor in pulse oximetry inaccuracies
as well. A 2020 study found that pulse oximeters over estimated O2 saturation in Black patients
when arterial oxygen saturation was ≤88%, causing occult hypoxemia to be overlooked (Sjoding
et al., 2020).

The present study found no relationship between O2 saturation and other tested variables.
However, the data did reveal differences in other variables when O2 saturation was low. In those
tested, there was a tendency to show changes in heart rate and blood pressure. While we could
not verify COVID-19 infection, there was something physiological occurring in the population.
Larger sample size may further highlight these changes due to the potential inclusion of SARSCoV-2 positive individuals.
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Other correlations expected to be present were between O2 saturation and blood pressure.
Oxygen saturation has been shown to be correlated with systolic blood pressure above 80 mmHg
(Hinkelbein, Genzwuerker, & Fiedler, 2005). However, the present study revealed a p = 0.347
and r = -0.1845. The negative r value is particularly interesting due to the inverse relationship
between these two variables.

Using pulse oximetry for the screening of COVID-19 can be unreliable. Pulse oximeters show
vast inaccuracies when O2 saturation is below 90%. COVID-19 patients can present with levels
as low as 50%; thus, pulse oximeters are not helpful to detect new COVID-19 infections. Instead,
using pulse oximeters for monitoring oxygen levels in those with a positive SARS-CoV-2 test
could be a lifesaving tool. Home-bound COVID-19 patients can use a pulse oximeter to monitor
their status and determine if they should seek medical attention or not. Further, many available
pulse oximeters have not been approved by the FDA; thus, a more widely validated method for
screening should be used. As previously mentioned, CO2 levels should be explored as a way to
monitor infection.

Other potentially useful screening methods
The present study also attempted to validate smell as a potential screening method. All
participants had the ability to determine a scent when asked; therefore, smell could not be
validated. A smell test could be a quick and straightforward way to screen for COVID-19 due to
nearly 60% of all COVID-19 patients presenting with hyposmia or anosmia (Whitcroft &
Hummel, 2020). Loss of smell is more prevalent in COVID-19 patients than in other diseases
(Printza & Constantinidis, 2020), and it is often one of the first symptoms to present, often
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appearing three days after infection; as such, it could be a proper screening method in the face of
the pandemic. A hypothetical danger to using a smell test could be the need to pull a mask down
below the nose. This opens the participant up to potential infection, or the participant could
release infectious particles into the air for others to become infected.

Heart rate is another possible method for monitoring for COVID-19 infection. COVID-19 has
demonstrated an ability to increase resting heart rate in a small perfect of COVID-19 patients
(Quer et al., 2020). However, the study reported there was not a significant enough change to
discern COVID-19 positive patients from negative patients. The effect COVID-19 has on heart
rate needs to be further studied to gauge its usefulness in screening for SARS-CoV-2.

Further benefits from the present study
The COVID-19 pandemic has severely impacted general mental health. In the United States,
40% of adults report worse mental health status in June 2020 than in June 2019 (Czeisler et al.,
2020). Implementing the extra safeguards tested in this study can lower these rates by allowing
more people to interact. Thus, potential benefits from this study include an added level of
protection during screening to allow for more in-person activities such as in-person classes.

Limitations
Potential limitations of the present study include small sample size, lack of follow-up, and lack
of equilibration before taking blood pressure. Another significant limitation for the population is
the requirement to be symptom-free. In order for students to be on campus, they must have been
symptom-free for 48 hours and complete a questionnaire. Prospective investigations were
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hampered by cancelled classes, quarantines, and positive tests which shut down remaining
testing through much of Fall 2020.

Conclusion
The ongoing COVID-19 pandemic has brought to light flaws in well-established medical testing
devices. The most prominent example of these is the inaccuracies of non-contact infrared
thermometers. NCIT’s are inaccurate at temperatures at or above 99.5ºF; as such, they are an
ineffective way to screen for fever associated with COVID-19. The present study revealed
NCIT’s show no relationship between temporal temperatures and non-contact forehead
measures, further reducing their accuracy for application. Blood pressure is another ineffective
method for screening due to the lack of research on how COVID-19 affects blood pressure
without preexisting conditions. Pulse oximeters show reduced accuracy when blood oxygen
levels fall below 80%. Therefore, O2 saturation is not an effective way to screen for COVID-19
infection due to the high prevalence of COVID-19 patients showing hypoxia as low as 50%.
Heart rate could be another screening method; however, it is unknown how SARS-CoV-2 affects
the heart due to lack of research. Finally, smell may be a reliable method to screen for COVID19 due to the high prevalence of anosmia and early presentation when infected.

Special Thanks
I want to give a special thank you to Dr. Hew-Butler. She has been a fantastic mentor these past
two years. I have learned a lot from her about exercise physiology and research and how
challenging it can be. My college experience would not have been remotely close to what it was

S.O.S. FOR COVID-19

Hughes 23

without her. I also want to thank Val and Matt for being a second guide when Dr. Hew was not
there.

I look forward to continuing research with her and to furthering our relationship.

I also want to thank my parents. They have been incredible role models throughout my life. They
have also been my biggest supporters from day one. They tell me to take every opportunity I can
and push me to do my best. They pushed me to pursue my dreams and were nothing but
supportive when I changed my plans (more than once). The work ethic they have instilled in me
has given me the ability to write this 20-page paper and continue to earn a doctor of physical
therapy.

S.O.S. FOR COVID-19

Hughes 24

References
Althubaiti, A. (2016). Information bias in health research: Definition, pitfalls, and adjustment
methods. Journal of Multidisciplinary Healthcare, 2016(9), 211.
doi:10.2147/jmdh.s104807
Blahd Jr., W. H., MD, FACEP, Husney, A., MD, Romito, K., MD, O'Connor, H. M., MD,
&amp; Messenger, D., MD. (2020, February 26). Fever temperatures: Accuracy and
comparison. Retrieved April 19, 2021, from https://www.cigna.com/individualsfamilies/health-wellness/hw/medical-topics/fever-temperatures-tw9223
Bridges, E., &amp; Thomas, K. (2009). Noninvasive measurement of body temperature in
critically ill patients. Critical Care Nurse, 29(3), 94-97. doi:10.4037/ccn2009132
Center for Devices and Radiological Health. (2021, February 19). Pulse oximeter accuracy
and limitations. Retrieved April 22, 2021, from https://www.fda.gov/medicaldevices/safety-communications/pulse-oximeter-accuracy-and-limitations-fda-safetycommunication
Centers for Disease Control and Prevention [CDC]. (2017, June 30). Definitions of Symptoms
for Reportable Illnesses. U.S. Department of Health and Human Services.
https://www.cdc.gov/quarantine/air/reporting-deaths-illness/definitions-symptomsreportable-illnesses.html
Chan, A. T., Drew, D. A., Nguyen, L. H., Joshi, A. D., Ma, W., Guo, C., . . . Spector, T.
(2020). The coronavirus Pandemic EPIDEMIOLOGY (COPE) CONSORTIUM: A
call to action. Cancer Epidemiology Biomarkers &amp; Prevention, 29(7), 12831289. doi:10.1158/1055-9965.epi-20-0606

S.O.S. FOR COVID-19

Hughes 25

Chan, W. P., Kosik, R. O., &amp; Wang, C. J. (2021). Considerations and a call to action for
the use OF noncontact FOREHEAD Infrared handheld Thermometers during the
COVID-19 pandemic. Journal of Global Health, 11. doi:10.7189/jogh.11.03023
Chen, Z., Wang, H., Wang, Y., Lin, H., Zhu, X., &amp; Wang, Y. (2021). Use of noncontact infrared thermometers in rehabilitation patients: A randomized controlled
study. Journal of International Medical Research, 49(1), 030006052098461.
doi:10.1177/0300060520984617
Czeisler, M. É, Lane, R. I., Petrosky, E., Wiley, J. F., Christensen, A., Njai, R., . . .
Rajaratnam, S. M. (2020). Mental health, substance use, and suicidal ideation during
the Covid-19 Pandemic — United STATES, JUNE 24–30, 2020. MMWR. Morbidity
and Mortality Weekly Report, 69(32), 1049-1057. doi:10.15585/mmwr.mm6932a1
Dasgupta, A., Kalhan, A., &; Kalra, S. (2020). Long term complications and rehabilitation of
COVID-19 Patients. Journal of the Pakistan Medical Association, (0), 1.
doi:10.5455/jpma.32
Dunleavy, K. J. (2010). Which core body temperature measurement method is most
accurate? Nursing, 40(12), 18-19. doi:10.1097/01.nurse.0000390678.95642.7f
Elezagic, D., Johannis, W., Burst, V., Klein, F., &amp; Streichert, T. (2020). Venous blood
gas analysis in patients With COVID-19 symptoms in the early assessment of Virus
positivity. Journal of Laboratory Medicine, 45(1). doi:10.1515/labmed-2020-0126
Gavish, B., Ben-Dov, I. Z., &amp; Bursztyn, M. (2008). Linear relationship between systolic
and diastolic blood PRESSURE monitored over 24 h: Assessment and correlates.
Journal of Hypertension, 26(2), 199-209. doi:10.1097/hjh.0b013e3282f25b5a

S.O.S. FOR COVID-19

Hughes 26

Ghebreyesus Adhanom, T. (2020). WHO director-general's opening remarks at the media
briefing on COVID-19 - 11 march 2020. Retrieved from
https://www.who.int/director-general/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Goha, A., Mezue, K., Edwards, P., Nunura, F., Baugh, D., &amp; Madu, E. (2020). COVID ‐
19 and the heart: An update for clinicians. Clinical Cardiology, 43(11), 1216-1222.
doi:10.1002/clc.23406
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020). Management of
post-acute covid-19 in primary care. BMJ, M3026. doi:10.1136/bmj.m3026

Hinkelbein, J., Genzwuerker, H. V., & Fiedler, F. (2005). Detection of a systolic pressure
threshold for reliable readings in pulse oximetry. Resuscitation, 64(3), 315-319.
doi:10.1016/j.resuscitation.2004.10.006

Hu, B., Guo, H., Zhou, P., & Shi, Z. (2020). Characteristics of SARS-CoV-2 and COVID-19.
Nature Reviews. Microbiology, , 1-14. doi:10.1038/s41579-020-00459-7
Indwiani Ysrafil, Y. (2020). Severe acute respiratory syndrome coronavirus 2 (sars-cov-2):
An overview of viral structure and host response. Diabetes &amp; Metabolic
Syndrome: Clinical Research &amp; Reviews, 14(4), 407-412.
doi:10.1016/j.dsx.2020.04.020

Khan, S., Saultry, B., Adams, S., Kouzani, A. Z., Decker, K., Digby, R., & Bucknall, T.
(2020). Comparative accuracy testing of non-contact infrared thermometers and
temporal artery thermometers in an adult hospital setting. American Journal of
Infection Control. doi:10.1016/j.ajic.2020.09.012

S.O.S. FOR COVID-19

Hughes 27

Luers, J. C., Rokohl, A. C., Loreck, N., Wawer Matos, P. A., Augustin, M., Dewald, F., ... &
Heindl, L. M. (2020). Olfactory and gustatory dysfunction in coronavirus disease
2019 (COVID-19). Clinical Infectious Diseases, 71(16), 2262-2264.
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., . . .
Wan, E. Y. (2021). Post-acute COVID-19 SYNDROME. Nature Medicine.
doi:10.1038/s41591-021-01283-z
Niven, D. J., Gaudet, J. E., Laupland, K. B., Mrklas, K. J., Roberts, D. J., &amp; Stelfox, H.
T. (2015). Accuracy of peripheral thermometers for estimating temperature. Annals
of Internal Medicine, 163(10), 768. doi:10.7326/m15-1150
Oran, D. P., &amp; Topol, E. J. (2021). The proportion of sars-cov-2 infections that are
asymptomatic. Annals of Internal Medicine. doi:10.7326/m20-6976
Pastor-Barriuso, R., Banegas, J. R., Damin, J., Appel, L. J., &amp; Guallar, E. (2003).
Systolic blood pressure, diastolic blood pressure, and pulse pressure: An evaluation of
their joint effect on mortality. Annals of Internal Medicine, 139(9), 731.
doi:10.7326/0003-4819-139-9-200311040-00007
Printza, A., &amp; Constantinidis, J. (2020). The role of SELF-REPORTED smell and Taste
disorders in suspected COVID‑19. European Archives of Oto-Rhino-Laryngology,
277(9), 2625-2630. doi:10.1007/s00405-020-06069-6
Quer, G., Radin, J. M., Gadaleta, M., Baca-Motes, K., Ariniello, L., Ramos, E., . . .
Steinhubl, S. R. (2020). Wearable sensor data and self-reported symptoms FOR
COVID-19 detection. Nature Medicine, 27(1), 73-77. doi:10.1038/s41591-020-1123x

S.O.S. FOR COVID-19

Hughes 28

Rabi, F. A., Al Zoubi, M. S., Kasasbeh, G. A., Salameh, D. M., &amp; Al-Nasser, A. D.
(2020). SARS-CoV-2 and Coronavirus Disease 2019: What we know so far.
Pathogens, 9(3), 231. doi:10.3390/pathogens9030231
Shah, H., Khan, M. S., Dhurandhar, N. V., &amp; Hegde, V. (2021). The triumvirate: Why
hypertension, obesity, and diabetes are risk factors for adverse effects in patients With
covid-19. Acta Diabetologica. doi:10.1007/s00592-020-01636-z
Shajkofci, A. (2021). Correction of human forehead temperature variations measured by noncontact infrared thermometer. IEEE Sensors Journal, 1-1.
doi:10.1109/jsen.2021.3058958
Sjoding, M. W., Dickson, R. P., Iwashyna, T. J., Gay, S. E., &amp; Valley, T. S. (2020).
Racial bias in pulse oximetry measurement. New England Journal of Medicine,
383(25), 2477-2478. doi:10.1056/nejmc2029240
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., . . .
Wu, M. J. (2020). Symptom duration and risk factors for delayed return to usual
health Among outpatients With COVID-19 in a Multistate health care Systems
network — United STATES, March–June 2020. MMWR. Morbidity and Mortality
Weekly Report, 69(30), 993-998. doi:10.15585/mmwr.mm6930e1
Tobin, M. J., Laghi, F., & Jubran, A. (2020). Why COVID-19 silent hypoxemia is baffling to
physicians. American journal of respiratory and critical care medicine, 202(3), 356360.
Topol, E. J. (2020). COVID-19 can affect the heart. Science, 370(6515), 408-409.
doi:10.1126/science.abe2813

S.O.S. FOR COVID-19

Hughes 29

Wang, Y., Wang, Z., Tse, G., Zhang, L., Wan, E. Y., Guo, Y., ... & Liu, T. (2020). Cardiac
arrhythmias in patients with COVID‐19. Journal of Arrhythmia, 36(5), 827-836.
Whitcroft, K. L., & Hummel, T. (2020). Olfactory dysfunction in COVID-19: diagnosis and
management. Jama, 323(24), 2512-2514.
WHO coronavirus disease (COVID-19) dashboard. Retrieved from https://covid19.who.int

